Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Chordoma | 3 | 2023 | 349 | 1.160 |
Why?
|
Duodenum | 2 | 2019 | 495 | 0.970 |
Why?
|
Vascular Diseases | 2 | 2022 | 1162 | 0.760 |
Why?
|
Hepatitis | 1 | 2023 | 227 | 0.740 |
Why?
|
Idiopathic Pulmonary Fibrosis | 3 | 2022 | 522 | 0.740 |
Why?
|
Cholangitis, Sclerosing | 1 | 2022 | 179 | 0.710 |
Why?
|
Anus Diseases | 1 | 2020 | 54 | 0.700 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2023 | 282 | 0.670 |
Why?
|
Cholestasis | 1 | 2022 | 385 | 0.650 |
Why?
|
Ileum | 1 | 2022 | 558 | 0.650 |
Why?
|
Stomach | 2 | 2022 | 701 | 0.630 |
Why?
|
Anal Canal | 1 | 2020 | 376 | 0.580 |
Why?
|
Gastrointestinal Neoplasms | 3 | 2020 | 957 | 0.570 |
Why?
|
Asbestos | 1 | 2019 | 251 | 0.570 |
Why?
|
Cytomegalovirus Infections | 1 | 2023 | 837 | 0.540 |
Why?
|
Sarcoma, Kaposi | 1 | 2019 | 376 | 0.530 |
Why?
|
Precancerous Conditions | 1 | 2023 | 985 | 0.530 |
Why?
|
Intestinal Diseases | 2 | 2022 | 505 | 0.530 |
Why?
|
Focal Nodular Hyperplasia | 1 | 2015 | 29 | 0.500 |
Why?
|
Adenoma, Liver Cell | 1 | 2015 | 32 | 0.500 |
Why?
|
Lung Neoplasms | 7 | 2024 | 13586 | 0.500 |
Why?
|
Neoplasms, Complex and Mixed | 1 | 2015 | 35 | 0.490 |
Why?
|
Mastocytosis, Systemic | 1 | 2016 | 102 | 0.480 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2019 | 388 | 0.480 |
Why?
|
Doxycycline | 1 | 2017 | 349 | 0.480 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 2015 | 174 | 0.470 |
Why?
|
Liver Transplantation | 2 | 2023 | 2401 | 0.450 |
Why?
|
Gastric Mucosa | 1 | 2017 | 602 | 0.450 |
Why?
|
Complement Activation | 1 | 2015 | 447 | 0.440 |
Why?
|
Gastrointestinal Diseases | 1 | 2022 | 1205 | 0.440 |
Why?
|
Mesothelioma | 1 | 2019 | 811 | 0.410 |
Why?
|
Complement System Proteins | 1 | 2015 | 738 | 0.410 |
Why?
|
Bone Neoplasms | 3 | 2021 | 2565 | 0.390 |
Why?
|
Lung | 7 | 2022 | 10101 | 0.390 |
Why?
|
Pneumonia | 1 | 2022 | 2163 | 0.360 |
Why?
|
Abdominal Pain | 3 | 2022 | 1070 | 0.340 |
Why?
|
Crohn Disease | 1 | 2022 | 2295 | 0.320 |
Why?
|
Gene Silencing | 1 | 2015 | 1505 | 0.320 |
Why?
|
Influenza A Virus, H1N1 Subtype | 3 | 2020 | 452 | 0.310 |
Why?
|
Occupational Exposure | 1 | 2019 | 1807 | 0.310 |
Why?
|
Giant Cell Tumor of Bone | 2 | 2021 | 119 | 0.310 |
Why?
|
Stomach Neoplasms | 3 | 2024 | 1481 | 0.280 |
Why?
|
Intestinal Mucosa | 2 | 2020 | 3044 | 0.270 |
Why?
|
Immunohistochemistry | 8 | 2024 | 11095 | 0.260 |
Why?
|
Metallothionein | 1 | 2024 | 62 | 0.240 |
Why?
|
Tomography, Optical Coherence | 3 | 2022 | 2957 | 0.230 |
Why?
|
Hepatolenticular Degeneration | 1 | 2024 | 73 | 0.230 |
Why?
|
Diarrhea | 2 | 2022 | 1320 | 0.230 |
Why?
|
Biopsy | 4 | 2021 | 6792 | 0.230 |
Why?
|
Practice Guidelines as Topic | 1 | 2021 | 7454 | 0.220 |
Why?
|
Respiratory Insufficiency | 2 | 2023 | 1240 | 0.220 |
Why?
|
Anti-Bacterial Agents | 3 | 2023 | 7477 | 0.220 |
Why?
|
Humans | 53 | 2024 | 768171 | 0.210 |
Why?
|
Liver Neoplasms | 2 | 2017 | 4363 | 0.210 |
Why?
|
Glycerol | 1 | 2024 | 274 | 0.210 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2022 | 9419 | 0.210 |
Why?
|
Iron Overload | 1 | 2024 | 245 | 0.200 |
Why?
|
Fibrin | 1 | 2024 | 514 | 0.190 |
Why?
|
Endoscopy, Gastrointestinal | 2 | 2019 | 888 | 0.190 |
Why?
|
Tomography, X-Ray Computed | 3 | 2022 | 20762 | 0.190 |
Why?
|
Indocyanine Green | 1 | 2023 | 239 | 0.190 |
Why?
|
Colitis, Ischemic | 1 | 2021 | 32 | 0.190 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2024 | 1756 | 0.190 |
Why?
|
Collagen Type I | 1 | 2024 | 620 | 0.180 |
Why?
|
Receptors, Virus | 2 | 2015 | 651 | 0.180 |
Why?
|
Chondrosarcoma | 1 | 2023 | 306 | 0.180 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2022 | 219 | 0.180 |
Why?
|
Duodenitis | 1 | 2020 | 20 | 0.180 |
Why?
|
Enterocolitis | 1 | 2021 | 106 | 0.170 |
Why?
|
Skull Base Neoplasms | 1 | 2023 | 279 | 0.170 |
Why?
|
Genetic Predisposition to Disease | 2 | 2019 | 18065 | 0.170 |
Why?
|
Elasticity Imaging Techniques | 1 | 2024 | 398 | 0.170 |
Why?
|
Pulmonary Alveoli | 1 | 2022 | 665 | 0.170 |
Why?
|
Hepatitis B, Chronic | 1 | 2024 | 413 | 0.160 |
Why?
|
Smooth Muscle Tumor | 1 | 2020 | 65 | 0.160 |
Why?
|
Alkaline Phosphatase | 1 | 2022 | 864 | 0.160 |
Why?
|
Abdominal Injuries | 1 | 2022 | 362 | 0.160 |
Why?
|
Retinoblastoma Binding Proteins | 1 | 2019 | 101 | 0.160 |
Why?
|
Organ Preservation | 1 | 2022 | 393 | 0.160 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2022 | 622 | 0.160 |
Why?
|
Cytomegalovirus | 1 | 2023 | 753 | 0.160 |
Why?
|
Histocytochemistry | 1 | 2019 | 699 | 0.150 |
Why?
|
Tracheal Neoplasms | 1 | 2019 | 124 | 0.150 |
Why?
|
Chondroblastoma | 1 | 2018 | 47 | 0.150 |
Why?
|
Pulmonary Fibrosis | 1 | 2022 | 506 | 0.150 |
Why?
|
Positron-Emission Tomography | 2 | 2024 | 6669 | 0.150 |
Why?
|
Comparative Genomic Hybridization | 1 | 2019 | 474 | 0.150 |
Why?
|
Male | 27 | 2024 | 364731 | 0.150 |
Why?
|
Arthralgia | 1 | 2022 | 459 | 0.150 |
Why?
|
Adult | 19 | 2024 | 223646 | 0.140 |
Why?
|
Electron Transport Complex I | 1 | 2018 | 152 | 0.140 |
Why?
|
Sialic Acids | 2 | 2015 | 123 | 0.140 |
Why?
|
Diagnosis, Differential | 3 | 2022 | 13013 | 0.140 |
Why?
|
Interferons | 1 | 2020 | 720 | 0.140 |
Why?
|
Adenoma, Oxyphilic | 1 | 2018 | 152 | 0.140 |
Why?
|
Polymers | 1 | 2024 | 1630 | 0.130 |
Why?
|
Middle Aged | 19 | 2024 | 223487 | 0.130 |
Why?
|
Anus Neoplasms | 1 | 2020 | 336 | 0.130 |
Why?
|
SOXB1 Transcription Factors | 1 | 2018 | 286 | 0.130 |
Why?
|
Gastrointestinal Tract | 1 | 2022 | 840 | 0.130 |
Why?
|
DNA, Mitochondrial | 2 | 2018 | 872 | 0.130 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2019 | 664 | 0.130 |
Why?
|
Neoplasm Metastasis | 3 | 2024 | 4913 | 0.130 |
Why?
|
Bronchoscopy | 1 | 2021 | 914 | 0.130 |
Why?
|
Glutathione | 1 | 2018 | 589 | 0.130 |
Why?
|
Prognosis | 7 | 2020 | 30009 | 0.130 |
Why?
|
Cytodiagnosis | 1 | 2019 | 452 | 0.120 |
Why?
|
Aged | 17 | 2024 | 171502 | 0.120 |
Why?
|
Neoplasm Invasiveness | 2 | 2020 | 3620 | 0.120 |
Why?
|
Palate, Soft | 1 | 2015 | 100 | 0.120 |
Why?
|
Osteoblasts | 1 | 2021 | 1153 | 0.120 |
Why?
|
Female | 27 | 2024 | 397187 | 0.120 |
Why?
|
Observer Variation | 1 | 2021 | 2621 | 0.120 |
Why?
|
Pancreatic Neoplasms | 2 | 2024 | 5442 | 0.120 |
Why?
|
Chromosome Deletion | 1 | 2019 | 1385 | 0.120 |
Why?
|
Fever | 1 | 2022 | 1614 | 0.110 |
Why?
|
Liver Cirrhosis | 1 | 2024 | 1960 | 0.110 |
Why?
|
Antiviral Agents | 2 | 2024 | 3072 | 0.110 |
Why?
|
Young Adult | 8 | 2024 | 60066 | 0.110 |
Why?
|
Deglutition Disorders | 1 | 2019 | 640 | 0.110 |
Why?
|
Lung Diseases, Interstitial | 1 | 2022 | 940 | 0.110 |
Why?
|
DNA Copy Number Variations | 2 | 2019 | 2048 | 0.110 |
Why?
|
CD4 Lymphocyte Count | 1 | 2019 | 2596 | 0.110 |
Why?
|
Bone Density Conservation Agents | 1 | 2021 | 797 | 0.110 |
Why?
|
Adolescent | 9 | 2024 | 89169 | 0.110 |
Why?
|
Viral Tropism | 1 | 2013 | 102 | 0.100 |
Why?
|
Bacterial Infections | 1 | 2021 | 1397 | 0.100 |
Why?
|
Cell Lineage | 2 | 2021 | 2575 | 0.100 |
Why?
|
Sensitivity and Specificity | 2 | 2024 | 14729 | 0.100 |
Why?
|
RNA | 1 | 2022 | 2722 | 0.100 |
Why?
|
Nanoparticles | 1 | 2024 | 1986 | 0.100 |
Why?
|
Celiac Disease | 1 | 2020 | 820 | 0.100 |
Why?
|
Predictive Value of Tests | 2 | 2021 | 15453 | 0.100 |
Why?
|
Chromosome Aberrations | 1 | 2018 | 1778 | 0.100 |
Why?
|
Retrospective Studies | 9 | 2024 | 81760 | 0.100 |
Why?
|
Adenoma | 1 | 2022 | 2159 | 0.100 |
Why?
|
Hepatectomy | 1 | 2015 | 588 | 0.100 |
Why?
|
Dyspnea | 1 | 2019 | 1352 | 0.100 |
Why?
|
Gene Deletion | 1 | 2019 | 2674 | 0.090 |
Why?
|
Sarcoma | 1 | 2022 | 1806 | 0.090 |
Why?
|
Sequence Analysis, RNA | 1 | 2019 | 2040 | 0.090 |
Why?
|
Mycobacterium tuberculosis | 1 | 2022 | 1930 | 0.090 |
Why?
|
Selection, Genetic | 1 | 2015 | 877 | 0.090 |
Why?
|
Aged, 80 and over | 7 | 2021 | 59626 | 0.090 |
Why?
|
Leucovorin | 2 | 2024 | 643 | 0.090 |
Why?
|
Graft Rejection | 1 | 2023 | 4492 | 0.080 |
Why?
|
Mutation | 3 | 2019 | 30237 | 0.080 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2019 | 1901 | 0.080 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2024 | 4648 | 0.080 |
Why?
|
Influenza, Human | 1 | 2020 | 1541 | 0.080 |
Why?
|
Tuberculosis | 1 | 2022 | 2029 | 0.080 |
Why?
|
Administration, Oral | 1 | 2017 | 4034 | 0.080 |
Why?
|
Societies, Medical | 1 | 2021 | 3968 | 0.080 |
Why?
|
Neoplasm Staging | 2 | 2020 | 11244 | 0.080 |
Why?
|
Adaptation, Physiological | 1 | 2015 | 1312 | 0.080 |
Why?
|
Neoadjuvant Therapy | 1 | 2020 | 2907 | 0.080 |
Why?
|
Histones | 1 | 2018 | 2601 | 0.070 |
Why?
|
Esophageal Neoplasms | 1 | 2018 | 1668 | 0.070 |
Why?
|
Fluorouracil | 2 | 2024 | 1652 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 1 | 2018 | 6525 | 0.070 |
Why?
|
Fibrosis | 2 | 2024 | 2081 | 0.070 |
Why?
|
Neoplasm Proteins | 1 | 2018 | 3604 | 0.060 |
Why?
|
Reproducibility of Results | 2 | 2021 | 20225 | 0.060 |
Why?
|
Skin | 1 | 2019 | 4505 | 0.060 |
Why?
|
Paclitaxel | 2 | 2024 | 1733 | 0.060 |
Why?
|
Virus Replication | 1 | 2013 | 2458 | 0.060 |
Why?
|
In Situ Hybridization | 2 | 2020 | 1904 | 0.060 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2019 | 2442 | 0.060 |
Why?
|
Thyroid Neoplasms | 1 | 2018 | 2360 | 0.060 |
Why?
|
Host-Pathogen Interactions | 1 | 2013 | 1469 | 0.060 |
Why?
|
Mitochondria | 1 | 2018 | 3683 | 0.060 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2017 | 2334 | 0.060 |
Why?
|
Neoplasms | 2 | 2024 | 22371 | 0.060 |
Why?
|
Copper Radioisotopes | 1 | 2024 | 100 | 0.060 |
Why?
|
Ferrets | 2 | 2015 | 181 | 0.060 |
Why?
|
Gallium Radioisotopes | 1 | 2024 | 195 | 0.060 |
Why?
|
Child, Preschool | 3 | 2024 | 42669 | 0.050 |
Why?
|
Cell Line, Tumor | 3 | 2024 | 17142 | 0.050 |
Why?
|
Hepatitis B Surface Antigens | 1 | 2024 | 294 | 0.050 |
Why?
|
Follow-Up Studies | 3 | 2023 | 39354 | 0.050 |
Why?
|
Child | 5 | 2024 | 80917 | 0.050 |
Why?
|
Orthomyxoviridae Infections | 2 | 2015 | 255 | 0.050 |
Why?
|
Kidney Neoplasms | 1 | 2018 | 4282 | 0.050 |
Why?
|
Fluorescence | 1 | 2023 | 757 | 0.050 |
Why?
|
Skull Base | 1 | 2023 | 294 | 0.040 |
Why?
|
Surface-Active Agents | 1 | 2020 | 152 | 0.040 |
Why?
|
Hepatitis B virus | 1 | 2024 | 533 | 0.040 |
Why?
|
Infant | 2 | 2023 | 36535 | 0.040 |
Why?
|
Microvilli | 1 | 2020 | 235 | 0.040 |
Why?
|
Macaca fascicularis | 1 | 2022 | 912 | 0.040 |
Why?
|
Granuloma | 1 | 2022 | 329 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 2019 | 6975 | 0.040 |
Why?
|
Adenocarcinoma | 1 | 2017 | 6395 | 0.040 |
Why?
|
Chemokines | 1 | 2024 | 963 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 16044 | 0.040 |
Why?
|
Caspases | 1 | 2022 | 882 | 0.040 |
Why?
|
Hyperplasia | 1 | 2022 | 1151 | 0.040 |
Why?
|
Aspartic Acid Endopeptidases | 1 | 2020 | 308 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2017 | 22290 | 0.040 |
Why?
|
Carcinoma, Mucoepidermoid | 1 | 2019 | 91 | 0.040 |
Why?
|
Tumor Microenvironment | 2 | 2024 | 3948 | 0.040 |
Why?
|
Haploidy | 1 | 2018 | 127 | 0.040 |
Why?
|
Viral Load | 2 | 2020 | 3396 | 0.040 |
Why?
|
Protons | 1 | 2023 | 1113 | 0.040 |
Why?
|
Mice, Nude | 1 | 2024 | 3623 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2024 | 11878 | 0.040 |
Why?
|
Liver | 2 | 2024 | 7578 | 0.040 |
Why?
|
Necrosis | 1 | 2022 | 1616 | 0.040 |
Why?
|
Ecosystem | 1 | 2022 | 494 | 0.040 |
Why?
|
Perfusion | 1 | 2022 | 1401 | 0.040 |
Why?
|
Mucins | 1 | 2020 | 570 | 0.040 |
Why?
|
Phenotype | 1 | 2015 | 16726 | 0.040 |
Why?
|
Mice | 5 | 2024 | 82049 | 0.040 |
Why?
|
Endoderm | 1 | 2018 | 165 | 0.040 |
Why?
|
Immunophenotyping | 1 | 2022 | 1864 | 0.030 |
Why?
|
Autopsy | 1 | 2020 | 1011 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2024 | 36741 | 0.030 |
Why?
|
Animals | 7 | 2024 | 169285 | 0.030 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 2019 | 263 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2024 | 21207 | 0.030 |
Why?
|
Cyclin D1 | 1 | 2018 | 453 | 0.030 |
Why?
|
Epithelial Cells | 2 | 2020 | 3703 | 0.030 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2018 | 640 | 0.030 |
Why?
|
Fluorescent Dyes | 1 | 2023 | 1931 | 0.030 |
Why?
|
Immunity | 1 | 2020 | 1003 | 0.030 |
Why?
|
Radiopharmaceuticals | 1 | 2024 | 2735 | 0.030 |
Why?
|
Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2015 | 163 | 0.030 |
Why?
|
Intestine, Small | 1 | 2020 | 1217 | 0.030 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2018 | 525 | 0.030 |
Why?
|
Ischemia | 1 | 2022 | 1900 | 0.030 |
Why?
|
Telomerase | 1 | 2018 | 751 | 0.030 |
Why?
|
HIV Infections | 1 | 2019 | 17569 | 0.030 |
Why?
|
Embryonic Development | 1 | 2018 | 724 | 0.030 |
Why?
|
Biopsy, Fine-Needle | 1 | 2018 | 1132 | 0.030 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2019 | 4058 | 0.030 |
Why?
|
DNA, Neoplasm | 1 | 2018 | 1744 | 0.030 |
Why?
|
Respiratory System | 1 | 2015 | 564 | 0.020 |
Why?
|
Risk Factors | 1 | 2019 | 74944 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2024 | 65379 | 0.020 |
Why?
|
Cell Differentiation | 2 | 2021 | 11677 | 0.020 |
Why?
|
Immune Tolerance | 1 | 2020 | 2323 | 0.020 |
Why?
|
Hepatocytes | 1 | 2017 | 1247 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2022 | 3080 | 0.020 |
Why?
|
Virulence | 1 | 2013 | 1297 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2018 | 4120 | 0.020 |
Why?
|
Neutrophils | 1 | 2022 | 3786 | 0.020 |
Why?
|
Cell Survival | 1 | 2018 | 5789 | 0.020 |
Why?
|
Immunotherapy | 1 | 2024 | 4754 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2018 | 3610 | 0.020 |
Why?
|
Apoptosis | 1 | 2022 | 9527 | 0.020 |
Why?
|
Macrophages | 1 | 2020 | 5802 | 0.020 |
Why?
|
Swine | 1 | 2015 | 5997 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2013 | 6231 | 0.010 |
Why?
|
Incidence | 1 | 2022 | 21538 | 0.010 |
Why?
|
Survival Rate | 1 | 2018 | 12840 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2024 | 26379 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2019 | 8648 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2015 | 17623 | 0.010 |
Why?
|
Disease Progression | 1 | 2020 | 13668 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2018 | 14488 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2018 | 9540 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2018 | 9262 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2018 | 22380 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 54924 | 0.010 |
Why?
|
Signal Transduction | 1 | 2018 | 23648 | 0.010 |
Why?
|
Cohort Studies | 1 | 2017 | 41753 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2013 | 18349 | 0.010 |
Why?
|